.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Baxter
US Department of Justice
Merck
Fish and Richardson
Deloitte
Colorcon
AstraZeneca
Cipla
Federal Trade Commission

Generated: June 22, 2017

DrugPatentWatch Database Preview

Etoposide - Generic Drug Details

« Back to Dashboard

What are the generic sources for etoposide and what is the scope of etoposide freedom to operate?

Etoposide
is the generic ingredient in four branded drugs marketed by Teva Parenteral, Accord Hlthcare, Pierre Fabre, Hospira, Pharmachemie Bv, Watson Labs, Teva Pharms Usa, Mylan, Dava Pharms Inc, Watson Labs Inc, Corden Pharma, Fresenius Kabi Usa, West-ward Pharms Int, and Bristol Myers Squibb, and is included in eighteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for etoposide. Five suppliers are listed for this compound.

Summary for Generic Name: etoposide

Tradenames:4
Patents:1
Applicants:14
NDAs:18
Drug Master File Entries: see list11
Suppliers / Packagers: see list5
Bulk Api Vendors: see list97
Clinical Trials: see list1,116
Patent Applications: see list9,950
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:etoposide at DailyMed

Pharmacology for Ingredient: etoposide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dava Pharms Inc
VEPESID
etoposide
CAPSULE;ORAL019557-001Dec 30, 1986DISCNNoNo► Subscribe► Subscribe
Teva Pharms Usa
ETOPOSIDE
etoposide
INJECTABLE;INJECTION074284-001Feb 10, 1994DISCNNoNo► Subscribe► Subscribe
Mylan
ETOPOSIDE
etoposide
CAPSULE;ORAL075635-001Sep 19, 2001RXNoYes► Subscribe► Subscribe
Pierre Fabre
ETOPOSIDE
etoposide
INJECTABLE;INJECTION074813-001Jul 9, 1997DISCNNoNo► Subscribe► Subscribe
Teva Parenteral
ETOPOSIDE
etoposide
INJECTABLE;INJECTION074510-001Jun 29, 1995DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: etoposide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dava Pharms Inc
VEPESID
etoposide
CAPSULE;ORAL019557-001Dec 30, 19863,524,844► Subscribe
Corden Pharma
VEPESID
etoposide
INJECTABLE;INJECTION018768-001Nov 10, 19833,524,844► Subscribe
Dava Pharms Inc
VEPESID
etoposide
CAPSULE;ORAL019557-002Dec 30, 19863,524,844► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Dow
Healthtrust
Chubb
Colorcon
Daiichi Sankyo
Queensland Health
Novartis
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot